EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Advancing Biopharmaceutical Innovation Through Cell Encapsulation and Biomimetic Therapeutic Systems
My interest in biopharmaceutical engineering began during my senior year as an undergraduate For my capstone project I worked on the encapsulation of...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
Generative AI in Drug Discovery: From Molecular Design to Translational Impact
Generative AI is changing how scientists think about drug discovery Rather than searching existing compound libraries or modifying known scaffolds these models can propose chemical ideas under defined constraints
-
Techno Trends
Salanersen Receives FDA Breakthrough Status for Spinal Muscular Atrophy
Biogen has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to salanersen an investigational treatment for spinal muscular atrophy SMA
-
Projects
Siemens Invests $14 Million in Drummondville Plant Expansion to Advance Digital Manufacturing
Siemens Canada has completed a major expansion and modernisation project at its manufacturing facility in Drummondville Qubec The yearlong project represents an investment of approximately US million
-
Research Insights
Thymidylate synthase inhibitory drugs induce p53-dependent pathways differently
Thymidylate synthase TS is a key enzyme in thymidylate biosynthesis and an established target of chemotherapeutics such as fluorodeoxyuridine FdUR and raltitrexed RTX Inhibition of TS disrupts
-
White Papers
Accelerating In-Vitro Antibody Discovery with Artificial Intelligence
Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities
TOP ARTICLES
-
1
How to Build a Compliant Pharma Email Strategy Using Automation Tools
Kate Williamson
A pharma email strategy that is compliant and will be executed in a more automated manner is not only about automation, it is also about structured workflows, stringent data governance, and integrated...
-
2
Top Lead Generation Strategies for Pharma Companies: How to Deliver High-Quality Leads
Kate Williamson
This article discusses the methods of lead generation in a pharma business and considers such categories as B2B outreach, content marketing, LinkedIn, CRM, and the use of influencers. It addresses the...
-
3
Advances in Regenerative Medicine: Stem Cells and Tissue Engineering
Harry Callum
Forming new ideas of the regenerative medicine, which principles are based on cell and tissue engineering, bring changes in approach to the treatment. There is also an awareness of the embryonic stem...
-
4
How Telehealth Is Transforming Access to Care in Chronic Disease Management
Lesley Barton
For decades, the standard paradigm of chronic disease management has been reactive and episodic, anchored by intermittent, in-person consultations. This model leaves significant gaps in the continuum...
-
5
Antibiotic Resistance 101: What Everyone Needs to Know About Superbugs
Debi Jones
The two threats to global health are bacterial resistance because bacteria populations can modify themselves to become resistance to the essential medicines needed to manage infections. It defines the...
press releasesRead more...
EVERSANA Selected by Innovacell as Commercialization Partner to Advance Novel Cell Therapy ICEF15 in the United States
EVERSANA a leading provider of global commercialization services to the life sciences industry today announced it has been selected by Tokyobased biotechnology company Innovacell Inc as its exclusive
Lupin Receives Tentative Approval from U.S. FDA for Sugammadex Injection
Global pharma major Lupin Limited Lupin today announced that it has received tentative approval from the United States Food and Drug Administration US FDA for its Abbreviated New Drug Application
Aspen Neuroscience Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel (ANPD001) to Treat Parkinson’s Disease
Aspen Neuroscience Inc a clinicalstage regenerative medicine biotechnology company developing personalized autologous cell therapies today announced that sasineprocel ANPD its lead investigational
Verista Expands Automation and Validation Capabilities with Acquisition of Integral Solutions
Verista a leading provider of automation compliance and quality solutions for the life sciences industry announced the acquisition of Integral Solutions Based in Columbus OH Integral Solutions is a life sciences
Events Read more...
03 - 04
Aug 2026Clinical Pharmacology and Toxicology 2026
Dubai, UAE
11 - 12
Aug 2026Medical Device Safety Monitoring and Reporting
San Diego, CA, USA
19 - 21
Aug 2026ISPE Conference & Exhibition 2026
Suntec Singapore
20 - 21
Aug 2026Pharmaceutical Formulations 2026
London, UK
20 - 21
Aug 2026Novel Drug Delivery Systems 2026
London, UK
20 - 21
Aug 2026Advanced Clinical Research 2026
London, UK
25 - 27
Aug 2026CPHI Korea 2026
COEX, Seoul, Korea
26 - 27
Aug 2026BIOMEDevice 2026
Boston Convention & Exhibition...
LATEST NEWSRead more...
FDA Approves Meitheal’s Garzulys Biosimilar Insulin for Diabetes Treatment
Meitheal Pharmaceuticals has announced that the US Food and Drug Administration FDA has approved Garzulys insulin aspartfsan injection a biosimilar to NovoLog insulin aspart for the treatment of diabetes mellitus
Capsa Healthcare Launches RoboPharma Automation Platform Powered by Axona
Capsa Healthcare has introduced RoboPharma powered by Axona an integrated automation and enterprise software platform designed to support centralised pharmacy operations including
Octapharma to Invest US$1.5 Billion in First US Manufacturing Facility in South Carolina
Octapharma has announced plans to invest US billion in a new manufacturing and production facility at the Palmetto Research Park in Rock Hill South Carolina The project marks the companys first manufacturing site in the United States and is expected to create approximately full
TScan Therapeutics Doses First Patient in Phase 3 Trial of TSC-101 for Blood Cancers
TScan Therapeutics has dosed the first patient in its pivotal Phase ALLOHA trial evaluating TSC for the treatment of residual disease following allogeneic haematopoietic cell transplantation
Xencor to Receive US$105 Million From Alexion to Settle Ultomiris US Royalty Dispute
Xencor has reached an agreement with Alexion Pharma International Operations to resolve a commercial dispute over US royalties related to Ultomiris ravulizumabcwvz Under the settlement Xencor will receive US
DKSH Korea Expands Partnership with Novartis to Strengthen Hypertension Portfolio
DKSH Healthcare has expanded its strategic partnership with Novartis in South Korea by adding the hypertension medicines Diovan and Exforge to its prescription drug portfolio Under the agreement DKSH
